EUCTR2004-002925-39-SE进行中（未招募）不适用
A Phase II study of Temozolomide (Temodal) Given Continously 100mg/m2 for 21 Days in 28 Day cycles in Patients with Metastatic Melanoma.
Kliniken för onkologi, Karolinska Universitetssjukhuset, Solna0 个研究点目标入组 35 人开始时间: 2004年12月22日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Histologically proven melanoma
- •Evidence of metastatic disease with at least one mesurable metastatic site
- •Performance status WHO 0-2
- •Age >18 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Prior chemotherapy, biologic therapy or immunotherapy for metastatic disease
- •Evidence of brain metases
- •Frequent vomiting or medical condition which could interfere with oral medication intake
- •Any other active malignancies or previous malignancies within the last 5 years
- •Pregnancy or breast feeding
研究者
相似试验
已完成
不适用
Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)-C189 Colon, unspecified-C349 Bronchus or lung, unspecified-C760 Head, face and neck-C159 Oesophagus, unspecifiedOesophagus, unspecifiedColon, unspecifiedBronchus or lung, unspecifiedHead, face and neckC159C189C349C760PER-023-07SCHERING PLOUGH RESEARCH INSTITUTE,
进行中（未招募）
1 期
A Phase 2 Study of Temozolomide (SCH 52365) in Subjects With Advanced Aerodigestive Tract Cancers Selected for Methylation of O6-Methyl-Guanine-DNA Methyltransferase (MGMT) Promoter. - P04273Advanced Aerodigestive Tract Cancers (Colorectal Cancer (CRC), Non Small Cell Lung Cancer (NSCLC), Head & Neck (H & N), Esophageal Cancer).MedDRA version: 9.1 Level: LLT Classification code 10028980 Term: NeoplasmEUCTR2006-003169-15-ITSCHERING-PLOUGH160
进行中（未招募）
1 期
A Phase 2 Study of Temozolomide (SCH 52365) in Subjects With Advanced Aerodigestive Tract Cancers Selected for Methylation of O6-Methyl-Guanine-DNA Methyltransferase (MGMT) PromoterAdvanced Aerodigestive Tract Cancers (Colorectal Cancer (CRC), Non Small Cell Lung Cancer (NSCLC), Head & Neck (H & N), Esophageal Cancer)MedDRA version: 8.1 Level: LLT Classification code 10028980 Term: NeoplasmEUCTR2006-003169-15-GRSchering-Plough Research Institute160
进行中（未招募）
1 期
Randomized Phase II Study: Temozolomide (TMZ) Concomitant to Radiotherapy followed by sequential TMZ in Advanced NSCLC Patients with CNS Metastasis versus Radiotherapy aloneEUCTR2004-001749-13-ATAESCA Pharma GesmbH92
进行中（未招募）
1 期
A Phase 2 study of temozolomide (SCH 52365) in Subjects with Advanced Aerodigestive Tract Cancers Selected for Methylation of O6-Methyl-guanine-DNA Methyltransferase (MGMT) PromoterAdvanced Aerodigestive Tract Cancers (Colorectal Cancer (CRC), Non Small Cell Lung Cancer (NSCLC), Head and Neck (H&N), Esophageal CancerMedDRA version: 8.1 Level: LLT Classification code 10028980 Term: NeoplasmEUCTR2006-003169-15-CZSchering Plough Research Institute160